|
ZBTB39 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.359400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.025600E-01 |
| Normal-vs-Stage2 |
5.727700E-02 |
| Normal-vs-Stage3 |
3.355400E-03 |
| Normal-vs-Stage4 |
2.819000E-03 |
| Stage1-vs-Stage2 |
1.185800E-02 |
| Stage1-vs-Stage3 |
2.49679999997365E-06 |
| Stage1-vs-Stage4 |
1.96639999999748E-05 |
| Stage2-vs-Stage3 |
6.231600E-01 |
| Stage2-vs-Stage4 |
4.455800E-01 |
| Stage3-vs-Stage4 |
6.719800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.957960E-01 |
| Normal-vs-AfricanAmerican |
4.692000E-01 |
| Normal-vs-Asian |
3.281200E-01 |
| Caucasian-vs-AfricanAmerican |
9.974200E-01 |
| Caucasian-vs-Asian |
2.468200E-01 |
| AfricanAmerican-vs-Asian |
3.453400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.092230E-01 |
| Normal-vs-Female |
8.162000E-01 |
| Male-vs-Female |
1.300420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.475600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.712400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.029810E-01 |
| Normal-vs-Age(81-100Yrs) |
1.477750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.239400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.128200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.476200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.194770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.728400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.743370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.564100E-02 |
| Normal-vs-Grade 2 |
2.389400E-01 |
| Normal-vs-Grade 3 |
4.819300E-03 |
| Normal-vs-Grade 4 |
7.958400E-04 |
| Grade 1-vs-Grade 2 |
2.479800E-01 |
| Grade 1-vs-Grade 3 |
4.636800E-04 |
| Grade 1-vs-Grade 4 |
4.047900E-04 |
| Grade 2-vs-Grade 3 |
1.43279999997858E-06 |
| Grade 2-vs-Grade 4 |
1.9953000000017E-06 |
| Grade 3-vs-Grade 4 |
1.832370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.013600E-01 |
| Normal-vs-ccB subtype |
6.747500E-02 |
| ccA subtype-vs-ccB subtype |
2.964000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.236190E-01 |
| Normal-vs-N1 |
5.512200E-01 |
| N0-vs-N1 |
9.688800E-01 |
|
|
